Codis
St. Louis, MO (US HQ); Haverhill, UK (EU operations)
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (8)
○ EMA GMP
○ MHRA GMP
Quick Facts: Codis
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- St. Louis, MO (US HQ); Haverhill, UK (EU operations)
- Modalities
- Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Finished Dose Manufacturing, Commercial-Scale Spray Drying
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Codis
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSpray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Finished Dose Manufacturing, Commercial-Scale Spray Drying
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press8 articles
Broad modality coverage (6 modalities)
Recent News 8 articles
Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis - Fierce Pharma
Codis Unlocks Commercial-Scale Amorphous Solid Dispersions Manufacturing with GEA PSD4 Solvent Spray Dryer Investment - PR Newswire UK
Codis Unlocks UK Pharma Future with Landmark Manufacturing Investment - BriefGlance
Codis Launches as Global CDMO for Commercial Spray Drying and Amorphous Solid Dispersions - PR Newswire
Codis launches as global CDMO combining spray drying and amorphous solid dispersions - Manufacturing Chemist
Codis Raises Growth Capital to Expand Commercial Manufacturing; Welcomes 1315 Capital - PR Newswire
CODIS: A New Era in Pharma Innovation - Contract Pharma
Codis Appoints Steven Facer as Senior VP Sales and Marketing to Support the Haverhill, UK Facility - PA Media
Frequently Asked Questions About Codis
What is Codis's CDMO Signal Score?
Codis has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Codis for a manufacturing program?
Use the free AI matchmaker to compare Codis against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Bend Bioscience
Bend, OR
Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Multiparticulates, Modified Release, Small Molecule API
Serán Bioscience
Bend, OR
Small Molecule (Oral Solid Dose), Spray Dried Dispersion (SDD), Hot Melt Extrusion (HME), Nano-milling / Nanoparticulate, Fluid Bed Processing, Particle Engineering, Pulmonary / Inhaled Particulates, Nasal Drug Delivery, Finished Dose (tablets, capsules, OPCs, powder-in-bottle)
Sun Pharmaceutical Industries Ltd.
Mumbai, India
Small Molecule API, Oral Solid Dose, Sterile Injectables, Specialty Generics, Novel Chemical Entities (NCE) via CRAMS, Biologics (via CMO partnerships), Specialty/Innovative Medicines